Sotio
Overview
Sotio is a clinical-stage biotechnology company that focuses on developing next-generation cancer immunotherapies. As part of the PPF Group, it is building a diversified portfolio of oncology products through its own R&D, as well as through collaborations, in-licensing, investments, and M&A. Its pipeline includes antibody-drug conjugates (ADCs), immunocytokines, and other immuno-oncology programs. The company also serves as the biotechnology investment hub for its parent company, PPF Group, managing investments in other biotech firms.
Portfolio Companies
1
Website
sotio.comInvestments
| Company | Date | Stage | Lead |
|---|---|---|---|
| Cellestia Biotech AG | Dec 2018 | Series A | Lead |
Sector & Stage Mix
Industry, funding stage, and valuation band breakdowns.
FAQ
Where is Sotio based?
Sotio is headquartered in Prague, Praha, Hlavní město, Czech Republic.
When was Sotio founded?
Founding year information for Sotio is not publicly available.
How many portfolio companies does Sotio have?
Sotio has 1 portfolio company in Caplight's dataset.
What are some companies in Sotio's portfolio?
Portfolio companies visible on Caplight include Cellestia Biotech AG.
What was Sotio's most recent investment shown here?
Sotio's most recent investment in this portfolio sample was in Cellestia Biotech AG in 2018.
What sectors does Sotio focus on?
Sotio focuses on Healthcare & Life Sciences.
What company stages does Sotio focus on?
Sotio typically invests at the Early stage.